Cannabis Legalization and College Mental Health

Faria, Ludmila De; Mezey, Lillian; Winkler, Aaron

doi:10.1007/s11920-021-01231-1

Cited by 15 publications

(14 citation statements)

References 44 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In the United States, the sharpest increase in cannabis users following legalization has been in the 18-25-year-old college age population [3]. Interestingly, over-the-counter antihistamine-based sleep aid medication sales decreased 236% with the legalization of recreational cannabis in Colorado [4].…”

Section: Increased Use Of Cannabis Productsmentioning

confidence: 99%

Updates in the use of cannabis for insomnia

Earl¹,

Proano

2022

Current Opinion in Pulmonary Medicine

View full text Add to dashboard Cite

Purpose of reviewThis review aims to summarize recent updates in the area of cannabis use for insomnia.Recent findingsCannabis products have continued to become more potent, particularly in regard to delta-9- tetrahydrocannabinol (THC) concentration. Additionally, the use of cannabis has continued to become more accepted with less legal restrictions. The reported use of cannabis for relief of symptoms in sleep disorders appears to be increasing, however the specific effects of cannabinoids on sleep varies with cannabinoid type and concentration. Some evidence supports claims of efficacy of cannabinoids in sleep disorders such as insomnia, while other evidence is either lacking or in some cases contradictory. Regular cannabis use has been associated with withdrawal which can profoundly alter sleep. Also, clinicians should be aware of the potential effects of cannabis on the metabolism of other medications as well as the fact that cannabis use has been reported in a significant number of women in the periods before, during, and after pregnancy.SummaryCannabis use has been becoming more and more prevalent in the setting of relaxed restrictions and easier consumer level access to cannabis and cannabis products. A relative paucity of high quality evidence regarding the effects of cannabis on sleep and the treatment of insomnia symptoms remains. The optimal type, concentration, ratio, and dosage form of cannabinoids in the treatment of insomnia symptoms needs further clarification. As the trend of acceptance and use of cannabis continues, more high quality evidence to help guide clinicians in their recommendations will hopefully become available.

show abstract

Section: Increased Use Of Cannabis Productsmentioning

confidence: 99%

Updates in the use of cannabis for insomnia

Earl¹,

Proano

2022

Current Opinion in Pulmonary Medicine

View full text Add to dashboard Cite

show abstract

“…De Faria et al (2021) establecen la asociación entre el consumo de cannabis y efectos adversos psiquiátricos (psicosis, ansiedad y depresión), influenciada por el consumo temprano, periodos grandes de consumo y dosis altas de THC (De Faria et al, 2021). Asimismo, Copeland (Copeland et al, 2022) y Hammond (Hammond, 2022) afirman que el uso diario acumulativo de cannabis en la edad temprana, se relaciona con diversos trastornos a largo plazo, entre ellos los de tipo psiquiátrico.…”

Section: Asociación Con Patología Psiquiátricaunclassified

Consecuencias del consumo de cannabis. Revisión narrativa

Ferri-Reig¹,

Sanchez-Perona²

2022

RED

View full text Add to dashboard Cite

El cannabis es la tercera droga más consumida a nivel mundial, tras el alcohol y el tabaco. En el entorno actual, con presiones para su legalización, se realizó una revisión narrativa en base a la literatura reciente, para actualizar las evidencias sobre los efectos de su consumo con fines recreativos. Se seleccionaron 19 artículos sobre consecuencias a nivel orgánico y 6 sobre acciones nocivas en la esfera psiquiátrica. A nivel orgánico, existe asociación entre el consumo de cannabis y patología cardiovascular (IAM, ACV, arritmias y con muerte súbita); a nivel respiratorio, hay asociación con bronquitis crónica y con la alteración de los volúmenes pulmonares. Se ha visto riesgo oncológico con el cáncer testicular no seminoma y más probabilidad de desarrollar cáncer primario de orofaringe. En el embarazo, hay asociación con el riesgo de bajo peso al nacer y aumento de ingresos en UCI de los neonatos. A nivel cognitivo, se han demostrado deficiencias en la memoria, atención y procesamiento, así como a la hora de conducir. A nivel psiquiátrico, se observa una relación del consumo con el desarrollo de esquizofrenia, psicosis y ansiedad, junto con depresión, sin que su frecuencia y presentación clínica se hayan modificado en los últimos 5 años.

show abstract

“…The current study helps to expand the current literature on outcomes of substance abuse after total joint arthroplasty and can serve to help educate patients of potential complications after their TKA.A lthough cannabis has been used recreationally within the United States for many years, its use is becoming a commonplace in modern society. [1][2][3][4] Since 2012, 11 US states have legalized cannabis for recreational use. 5 In a cross-sectional study performed by the National Institutes of…”

mentioning

confidence: 99%

“…Although cannabis has been used recreationally within the United States for many years, its use is becoming a commonplace in modern society. 1-4 Since 2012, 11 US states have legalized cannabis for recreational use. 5 In a cross-sectional study performed by the National Institutes of Health, cannabis use rose nearly 100% from 2015 to 2016 from 4.1 to 9.5% within the US adult population.…”

mentioning

confidence: 99%

The Association of Cannabis Use Disorder and Perioperative Complications After Primary Total Knee Arthroplasty

Weisberg

Magruder

et al. 2022

J Am Acad Orthop Surg

View full text Add to dashboard Cite

Introduction: Although studies have shown the implications of substance use on total joint arthroplasty, studies investigating the association of patients exclusively who have cannabis use disorder (CUD) after primary total knee arthroplasty (TKA) are sparse. As such, this study analyzed a private payor database to assess the relationship of CUD after primary TKA. Methods: Data from the Mariner data set were used to identify patients who have CUD undergoing primary TKA. Patients with CUD were ratio matched 1:5 to a comparison population by age, sex, and comorbidities, yielding 55,553 patients in the study (n = 9,260) and case-matched (n = 46,293) population. Variables compared included in-hospital length of stay, complications, and costs. A P value of less than 0.003 was considered statistically significant. Results: Patients with CUD were found to have longer in-hospital length of stay (3.61 versus 2.07 days, P , 0.0001), in addition to higher frequency and odds ratio (OR) of medical (28.08 versus 12.5; OR, 1.50, P , 0.0001) and prostheses-related complications (9.63 versus 5.16%; OR, 1.56, P , 0.0001). Patients with CUD also incurred significantly higher episode of care costs ($29,025.34 versus $24,258.17, P , 0.0001). Conclusion:With the continued legalization of cannabis use across the United States, studies investigating the association of cannabis on outcomes after primary TKA are limited. The current study helps to expand the current literature on outcomes of substance abuse after total joint arthroplasty and can serve to help educate patients of potential complications after their TKA.A lthough cannabis has been used recreationally within the United States for many years, its use is becoming a commonplace in modern society. [1][2][3][4] Since 2012, 11 US states have legalized cannabis for recreational use. 5 In a cross-sectional study performed by the National Institutes of

show abstract

Cannabis Legalization and College Mental Health

Cited by 15 publications

References 44 publications

Updates in the use of cannabis for insomnia

Updates in the use of cannabis for insomnia

Consecuencias del consumo de cannabis. Revisión narrativa

The Association of Cannabis Use Disorder and Perioperative Complications After Primary Total Knee Arthroplasty

Contact Info

Product

Resources

About